Pricing Log in Create free account

Arcturus Therapeutics Holdings Inc. (ARCT) vs Contineum Therapeutics, Inc. (CTNM)

Arcturus Therapeutics Holdings Inc. and Contineum Therapeutics, Inc. are both Biotechnology companies. Arcturus Therapeutics Holdings Inc. and Contineum Therapeutics, Inc. are of similar size ($320.3M and $297.2M). Contineum Therapeutics, Inc. has the higher net margin (0.00% vs −317.6%) and the lower return on invested capital (−1,334.4% vs 0.00%). Across the 12 metrics below, Contineum Therapeutics, Inc. leads on 9 and Arcturus Therapeutics Holdings Inc. on 3.

Valuation

Metric ARCT CTNM Biotechnology median
P/E n/m n/m 8.50
P/S 10.01 n/m 9.71
P/B 1.71 1.10 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 6.06 n/m 9.21
Earnings yield (32.01%) (24.64%) (33.15%)
Free cash flow yield (24.76%) (20.33%) (25.50%)

Profitability

Metric ARCT CTNM Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (348.32%) 0.00% 0.00%
Net margin (317.61%) 0.00% 0.00%
Free cash flow margin (247.79%) 0.00% 0.00%
Return on equity (46.31%) (28.01%) (56.36%)
Return on assets (34.96%) (26.57%) (48.04%)
Return on invested capital 0.00% (1,334.41%) 0.00%

Growth

Metric ARCT CTNM Biotechnology median
Revenue growth (TTM) (75.95%) — 6.02%
EPS growth (last fiscal year) 20.00% 0.46% 30.26%
Revenue growth, 5-year CAGR 53.78% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ARCT CTNM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.88 37.17 4.72
Net debt to EBITDA 3.15 3.88 0.96

Dividend

Metric ARCT CTNM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ARCT CTNM Biotechnology median
Market cap 320.32m 297.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack